High sensitive CRP level is associated with intermediate and high syntax score in patients with acute coronary syndrome

International Heart Journal

Volumn 56, Issue 4, 2015, Pages 377-380

  Karadeniz, Muhammed ^a   Duran, Mustafa ^a   Akyel, Ahmet ^a   Yarlıoğlueş, Mikail ^a   Öcek, Adil Hakan ^a   Çelik, İbrahim Etem ^a   Kılıç, Alparslan ^a   Yalcin, Ahmet Arif ^b   Ergün, Gökhan ^a   Murat, Sani Namık ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Training and Research Hospital   (Turkey)

Author keywords

Coronary artery disease; Inflammation; Severity of atherosclerosis

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; INFLAMMATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; AGED; BLOOD; COMPLICATION; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TURKEY;

ACUTE CORONARY SYNDROME; AGED; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TROPONIN; TURKEY;

EID: 84936997034     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-299     Document Type: Article

References (34)

1. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-27.
2. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009; 5: 50-6.
3. SYNTAX Working Group. SYNTAX score calculator. Available at: http://www.syntaxscore.com. Accessed April 8, 2015.
4. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol 2011; 57: 2389-97.
5. Valgimigli M, Serruys PW, Tsuchida K, et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007; 99: 1072-81.
6. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009; 2: 302-8.
7. Huang G, Zhao JL, Du H, Lan XB, Yin YH. Coronary score adds prognostic information for patients with acute coronary syndrome. Circ J 2010; 74: 490-5.
8. van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 2009; 135: 60-5.
9. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005; 45: 1397-405.
10. Yan AT, Yan RT, Tan M, et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. Am J Cardiol 2005; 96: 913-6.
11. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-22.
12. Weber M, Dill T, Arnold R, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 2004; 148: 612-20.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol 2013; 168: 5126-34. (Review)
15. Zethelius B, Berglund L, Sundström J, et al. Use of multiple biomarkers to improve the prediction of death fromcardiovascular causes. N Engl JMed 2008; 358: 2107-16.
16. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-40.
17. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462-6.
18. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343: 1139-47.
19. Mueller C, Buettner HJ, Hodgson JM, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-5.
20. Bogaty P, Boyer L, Simard S, et al. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol 2008; 51: 2339-46.
21. Assadpour Piranfar M. The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis. Int Cardiovasc Res J 2014; 8: 6-8.
22. Habib SS, A Al Masri A. Relationship of high sensitivity C-reactive protein with presence and severity of coronary artery disease. Pak J Med Sci 2013; 29: 1425-9.
23. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-26. (Review)
24. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95. (Review)
25. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004; 109: IV6-19. (Review)
26. Abhashi SA, Kryeziu FU, Nazreku FD. Increased carotid intima– media thickness associated with high hs-CRP levels is a predictor of unstable coronary artery disease. Cardiovasc J Afr 2013; 24: 270-3.
27. Suzuki M, Saito M, Nagai T, Saeki H, Kazatani Y. Systemic versus coronary levels of inflammation in acute coronary syndromes. Angiology 2006; 57: 459-63.
28. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 2010; 31: 2087-91. (Review)
29. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis. Hypertension 2004; 44: 6-11. (Review)
30. Devaraj S, Singh U, Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009; 55: 229-38. (Review)
31. Duran M, Uysal OK, Gunebakmaz O, et al. Glomerular filtration rate is associated with burden of coronary atherosclerosis in patients with acute coronary syndrome. Angiology 2014; 65: 350-6.
32. Duran M, Uysal OK, Yılmaz Y, et al. Serum gamma-glutamyltransferase and the burden of atherosclerosis in patients with acute coronary syndrome. Turk Kardiyol Dern Ars 2013; 41: 275-81.
33. Duran M, Kalay N, Akpek M, et al. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology 2012; 63: 448-52.
34. Aksakal E, Tanboga IH, Kurt M, et al. Predictors of coronary lesions complexity in patients with stable coronary artery disease. Angiology 2013; 64: 304-9.